Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Int Urol Nephrol ; 31(2): 263-7, 1999.
Artigo em Inglês | MEDLINE | ID: mdl-10481973

RESUMO

The serum levels of lipids, apolipoproteins and lipoprotein ratios in 19 healthy persons and 20 patients with uraemia not dialyzed were determined. Based on creatinine level the patients were divided into two groups: L (serum creatinine 2-5 mg/dl) and H (serum creatinine 5-10 mg/dl). Dyslipoproteinaemia in uraemic patients is already manifested in the early stages of the disease through its abnormal apolipoproteins rather than lipid profile and it suggests a high risk of atherosclerosis.


Assuntos
Arteriosclerose/etiologia , Hiperlipoproteinemias/complicações , Falência Renal Crônica/sangue , Lipídeos/sangue , Lipoproteínas/sangue , Adulto , Apolipoproteínas/sangue , Arteriosclerose/sangue , Creatina/sangue , Feminino , Humanos , Hiperlipoproteinemias/sangue , Falência Renal Crônica/complicações , Masculino , Pessoa de Meia-Idade , Fatores de Risco
2.
Int Urol Nephrol ; 30(6): 789-98, 1998.
Artigo em Inglês | MEDLINE | ID: mdl-10195875

RESUMO

The subjects of the studies were 31 haemodialysed (HD) patients with chronic renal insufficiency (CRI). In this group of patients the lipoprotein profile was determined and 8 patients were selected for further studies. During the study the patients were treated with cuprophane membranes for 6 months. For the next 6 months the same patients were treated using polysulfone dialysers, and for further 6 months HD with polysulfone dialysers was continued. Patients' sera were tested after every 6 months of treatment. The delta values were calculated as 6-month HD with polysulfone minus 6-month HD with cuprophane (deltaI) and 12-month HD with polysulfone minus 6-month HD with polysulfone (deltaII). We concluded that after long-term HD with low flux polysulfone treatment the lipoprotein profiles improved, but the mechanism of the process is not clear.


Assuntos
Materiais Biocompatíveis , Celulose/análogos & derivados , Falência Renal Crônica/sangue , Lipoproteínas/sangue , Membranas Artificiais , Polímeros , Diálise Renal/instrumentação , Sulfonas , Adolescente , Adulto , Arteriosclerose/sangue , Arteriosclerose/etiologia , Arteriosclerose/prevenção & controle , Feminino , Seguimentos , Humanos , Falência Renal Crônica/complicações , Falência Renal Crônica/terapia , Masculino , Pessoa de Meia-Idade
3.
Int Urol Nephrol ; 29(5): 597-601, 1997.
Artigo em Inglês | MEDLINE | ID: mdl-9413769

RESUMO

The clinical picture in chronic renal failure (CRF) shows great variability depending on age, sex, aetiology of disease, grades of renal injury and type of treatment. Significant increases of triglycerides (TG), low-density lipoprotein cholesterol (LDL-chol) and and apo B concentrations, significant decreases of high-density lipoprotein cholesterol (HDL-chol) levels and apo A and apo AI concentrations, and no significant changes in total cholesterol (TC) have been shown in CRF patients. Significant increases of TC/HDL-chol, LDL-chol/HDL-chol, apo B/apo AI and apo B/LDL-chol ratios were also demonstrated. That indicates a high risk of atherosclerosis even when total cholesterol levels are in the normal range. There were highly significant and positive correlations between TC/HDL-chol and LDL-chol/HDL-chol ratios, apo B and LDL-chol concentrations as well as between the apo B/apo AI and LDL-chol/HDL-chol ratios.


Assuntos
Colesterol/sangue , Falência Renal Crônica/sangue , Lipoproteínas/sangue , Adolescente , Adulto , Colesterol/biossíntese , Feminino , Humanos , Falência Renal Crônica/terapia , Lipoproteínas/biossíntese , Lipoproteínas HDL/biossíntese , Lipoproteínas HDL/sangue , Lipoproteínas LDL/biossíntese , Lipoproteínas LDL/sangue , Masculino , Pessoa de Meia-Idade , Valores de Referência , Diálise Renal
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...